Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.

191.75 2.01 −1.04%
Market cap
$52.8B
P/E
57.8×
Fwd P/E
37.7×
Dividend yield
2.07%
F-score
7/9
Altman Z
1.84
Beneish M
−2.64
Dividend safety
67/100

Becton, Dickinson and Company (BDX) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Becton, Dickinson and Company (BDX) trades at a price to free cash flow of 16.5×. Over the past ten years it has ranged from 11.3× (June 2026) to 54.9× (April 2022); the current reading is higher than 21% of that period. That is below the Medical Instruments & Supplies industry median of 25.2× and below the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 15.9× (9.97%)
FY2024 17.6× (35.77%)
FY2023 27.4× (17.74%)
FY2022 33.3× 79.17%
FY2021 18.6× (18.99%)
FY2020 23.0× 4.04%
FY2019 22.1× (17.01%)
FY2018 26.6× 47.08%
FY2017 18.1× 15.07%
FY2016 15.7× (0.42%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 13.0× 2.83%
Mar 2026 12.6× (23.76%)
Dec 2025 16.6× 4.46%
Sep 2025 15.9× (15.33%)
42 more quarters

Against its own ten years

Low 11.3× High 54.9×
Ten-year median 20.2×
Current reading's percentile 21

Price to free cash flow against peers

Company Price to free cash flow
SOLV Solventum Corporation compare n/m
MDLN Medline Inc. compare 13.4×
BAX Baxter International Inc. compare 16.1×
BDX Becton, Dickinson and Company 16.5×
ALC Alcon compare 20.2×
RMD ResMed Inc. compare 21.4×
ISRG Intuitive Surgical, Inc. compare 46.2×
WST West Pharmaceutical Services, Inc. compare 62.6×
RGEN Repligen Corporation compare 162×
Medical Instruments & Supplies industry median 25.2×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on BDX